CI

At a glance

ClinicalIndex Comparison Record
N/AActive· 2,415 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02105844
NCT02105844N/AActive

Swiss Atrial Fibrillation Cohort Study - SWISS AF

University Hospital, Basel, Switzerland·observational·Posted Apr 7, 2014·Updated Jul 9, 2025

In Brief

An observational study for Atrial Fibrillation. Active but no longer recruiting, targeting 2,415 participants across 1 site.

Detailed Summary

Swiss-AF is a prospective observational, multicentric cohort study in Switzerland. Overall, 2600 patients with documented atrial fibrillation aged \>65 years will be included and followed on a yearly basis. Yearly clinical examinations include a detailed questionnaire on personal characteristics, a resting electrocardiogram, neurocognitive function tests and questionnaires on disability and quality of life. Blood sampling and brain magnetic resonance imaging are scheduled at baseline and after 2 years of follow-up. The main study aims of this long term prospective study are to increase our knowledge on structural brain damage and its changes over time in patients with atrial fibrillation, to gain additional insights on the incidence and underlying mechanisms of cognitive decline in patients with atrial fibrillation and to evaluate the interrelationships of structural and functional brain damage in this population.

Study Details

Timeline

N/AActive
20142015201620172018201920202021202220232024202520262027202820292030
First PostedApr 7, 2014
Enrollment StartMar 1, 2014
Primary CompletionMar 1, 2030
TodayJul 2, 2026
Enrollment to primary: 16 yearsPosted 12.2 years agoPrimary completion in 3.7 years